Laurence N Charney is Director of TG THERAPEUTICS, INC.. Currently has a direct ownership of 237,479 shares of TGTX, which is worth approximately $6.39 Million. The most recent transaction as insider was on Jun 19, 2024, when has been sold 22,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 237K
0% 3M change
6.77% 12M change
Total Value Held $6.39 Million

Laurence N Charney Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 19 2024
BUY
Grant, award, or other acquisition
-
22,250 Added 8.57%
237,479 Common Stock
Mar 12 2024
SELL
Open market or private sale
$351,340 $15.97 p/Share
22,000 Reduced 9.27%
215,229 Common Stock
Jan 05 2024
SELL
Open market or private sale
$333,025 $19.03 p/Share
17,500 Reduced 6.87%
237,229 Common Stock
Sep 28 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 7.28%
254,729 Common Stock
Jan 04 2023
SELL
Open market or private sale
$333,000 $11.1 p/Share
30,000 Reduced 11.33%
234,729 Common Stock
Jul 20 2022
BUY
Grant, award, or other acquisition
-
43,732 Added 14.18%
264,729 Common Stock
Jun 18 2021
BUY
Grant, award, or other acquisition
-
60,000 Added 21.35%
220,997 Common Stock
LNC

Laurence N Charney

Director
New York, NY

Track Institutional and Insider Activities on TGTX

Follow TG THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TGTX shares.

Notify only if

Insider Trading

Get notified when an Tg Therapeutics, Inc. insider buys or sells TGTX shares.

Notify only if

News

Receive news related to TG THERAPEUTICS, INC.

Track Activities on TGTX